US Patent Issued to MANKIND PHARMA on June 30 for "Combination therapy of GPR119 agonists and DPP-4 inhibitors" (Indian Inventors)

ALEXANDRIA, Va., July 16 -- United States Patent no. 12,667,566, issued on June 30, was assigned to MANKIND PHARMA LTD. (New Delhi).

"Combination therapy of GPR119 agonists and DPP-4 inhibitors" was invented by Rakesh Iswar Patil (Manesar, India), Sazid Ali (Manesar, India), Srinivasa Reddy Bapuram (Manesar, India), Santosh Kumar Rai (Manesar, India) and Anil Kumar (Manesar, India).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to combinations of GPR119 receptor agonists with DPP-4 inhibitors and their use thereof for treating or preventing cardiovascular and metabolic disorders, including diabetes mellitus, non-alcoholic fatty liver disease (NAFLD), NAFL, NASH, dyslipidemia, and...